These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1576049)

  • 21. Permissive effect of molsidomine towards cardioprotective action of iloprost in myocardial ischemia in cats.
    Gryglewski RJ; Swies J; Chłopicki S; Niezabitowski P
    J Physiol Pharmacol; 1993 Sep; 44(3):313-8. PubMed ID: 7694690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The platelet rebound phenomenon during PGI2-infusion occurs at the receptor level.
    Steurer G; Fitscha P; Sinzinger H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):435-8. PubMed ID: 2465947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molsidomine, a nitric oxide donor, modulates rotational behavior and monoamine metabolism in 6-OHDA lesioned rats treated chronically with L-DOPA.
    Lorenc-Koci E; Czarnecka A; Lenda T; Kamińska K; Konieczny J
    Neurochem Int; 2013 Dec; 63(8):790-804. PubMed ID: 24090640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Streptokinase-prostacyclin--nitric oxide: in vivo interactions.
    Gryglewski RJ; Swies J
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():479-84. PubMed ID: 7537438
    [No Abstract]   [Full Text] [Related]  

  • 25. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
    Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E
    Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experimental studies on platelet preservation with prostaglandin I2 and its derivative (OP-41483) during cardiopulmonary bypass].
    Takeda H
    Hokkaido Igaku Zasshi; 1989 Jul; 64(4):500-11. PubMed ID: 2511131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the effects of a thromboxane synthase inhibitor or prostacyclin in combination with a phosphodiesterase inhibitor for prevention of experimental thrombosis and sudden death in rabbits.
    Smith EF; Egan JW
    J Pharmacol Exp Ther; 1987 Jun; 241(3):855-60. PubMed ID: 3298621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molsidomine enhances the protective activity of valproate against pentylenetetrazole-induced seizures in mice.
    Tutka P; Łuszczki J; Kleinrok Z; Arent K; Wielosz M
    J Neural Transm (Vienna); 2002 Apr; 109(4):455-66. PubMed ID: 11956965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term effect of molsidomine, a direct nitric oxide donor, as an add-on treatment, on endothelial dysfunction in patients with stable angina pectoris undergoing percutaneous coronary intervention: results of the MEDCOR trial.
    Barbato E; Herman A; Benit E; Janssens L; Lalmand J; Hoffer E; Chenu P; Guédès A; Missault L; Pirenne B; Cardinal F; Vercauteren S; Wijns W
    Atherosclerosis; 2015 Jun; 240(2):351-4. PubMed ID: 25875387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection against concanavalin A-induced hepatocyte apoptosis by molsidomine is time-dependent.
    Ding JW; Wang K; Brems JJ; Gamelli RL
    J Am Coll Surg; 2004 Jan; 198(1):67-77. PubMed ID: 14698313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The nitric oxide donor molsidomine improves survival and reduces hepatocyte apoptosis in cholestasis and endotoxemia.
    Brown KM; Brems JJ; Moazzam FN; Hartman GG; Gamelli RL; Ding JW
    J Am Coll Surg; 2003 Aug; 197(2):261-9. PubMed ID: 12892810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Molsidomine and nitric oxide in gastric cytoprotection].
    Laudanno OM; Cesolari JA; San Miguel P
    Acta Gastroenterol Latinoam; 1993; 23(2):65-9. PubMed ID: 8249529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentiation of the antithrombotic effect of prostacyclin by simultaneous administration of aminophylline in a canine model of coronary artery thrombosis.
    Romson JL; Hook BG; Lucchesi BR
    J Pharmacol Exp Ther; 1983 Nov; 227(2):288-94. PubMed ID: 6313894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic interaction between endothelium-derived NO and prostacyclin in pulmonary artery: potential role for K+ATP channels.
    Gambone LM; Murray PA; Flavahan NA
    Br J Pharmacol; 1997 May; 121(2):271-9. PubMed ID: 9154337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelets, von Willebrand factor, and prostaglandin I2.
    Moake JL; Tang SS; Olson JD; Troll JH; Cimo PL; Davies PJ
    Am J Physiol; 1981 Jul; 241(1):H54-9. PubMed ID: 6787937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitric oxide complements prostacyclin in the regulation of endothelial thromboresistance under flow conditions.
    Korbut R; Ocetkiewicz A; Gryglewski RJ
    Methods Find Exp Clin Pharmacol; 1993 Apr; 15(3):179-81. PubMed ID: 8332034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitric oxide and prostacyclin are involved in antithrombotic action of captopril in venous thrombosis in rats.
    Pawlak R; Chabielska E; Golatowski J; Azzadin A; Buczko W
    Thromb Haemost; 1998 Jun; 79(6):1208-12. PubMed ID: 9657449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of molsidomine and its active metabolite SIN-1 on fibrinolysis and platelet aggregation.
    Basista M; Grodzińska L; Swies J
    Thromb Haemost; 1985 Dec; 54(4):746-9. PubMed ID: 3911480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The superoxide dismutase mimetic, tempol, blunts right ventricular hypertrophy in chronic hypoxic rats.
    Elmedal B; de Dam MY; Mulvany MJ; Simonsen U
    Br J Pharmacol; 2004 Jan; 141(1):105-13. PubMed ID: 14656807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH; Haslam RJ
    Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.